文献速递神经核医学

改善淀粉样蛋白负荷定量及相关生物标志物截断点:首个伴脑血管病重叠的新加坡淀粉样蛋白队列结果

Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-12-20

该研究分析186名伴血管疾病重叠的亚洲参与者[11C]PiB-PET淀粉样蛋白图像,实施新的定量流程,包括运动校正、基于MRI分割的SUVr定量及无MRI的SUVr定量。研究引入AβL和ns两个新生物标志物,确定截断点并发现AβL与认知测试关联增加29.5%,ns对脑微出血等敏感。结论认为该流程可对所有受试者完成定量。

要点

  • 受试者运动影响测量准确性,但对视觉评级和截断点确定影响有限。
  • 无MRI分割时SUVr计算可对所有受试者可靠进行,需要分割时10%的病例分割失败或质量欠佳。
  • 新生物标志物AβL与认知测试关联增加29.5%,效应量较SUVr增加;ns对脑微出血等敏感。

核心结论

  • 针对该非典型队列的淀粉样蛋白定量最优处理可对所有受试者完成定量,产生SUVr值和两个新生物标志物AβL和ns。

研究设计与样本

  • 研究纳入186名伴血管疾病重叠的亚洲参与者,分析其[11C]PiB-PET淀粉样蛋白图像。

主要发现

  • 受试者运动影响测量结果准确性,但对视觉评级和截断点确定影响有限。
  • 需要MRI分割时,10%的病例分割失败或质量欠佳;无MRI分割时SUVr计算可对所有受试者可靠进行。
  • 新生物标志物AβL与认知测试的关联增加29.5%,且与SUVr相比阳性与阴性扫描间效应量增加。
  • ns对脑微出血、白质高信号、体积和年龄敏感。
  • 基于MRI分割的SUVr、无分割的SUVr和AβL的截断点分别为1.56、1.39和25.5。

关键数值与推荐

  • 基于MRI分割的SUVr截断点为1.56。
  • 无MRI分割的SUVr截断点为1.39。
  • AβL截断点为25.5。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 受试者运动影响测量结果准确性。
  • 需要MRI分割时10%的病例分割失败或质量欠佳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The analysis of the [11C]PiB-PET amyloid images of a unique Asian cohort of 186 participants featuring overlapping vascular diseases raised the question about the validity of current standards for amyloid quantification under abnormal conditions. In this work, we implemented a novel pipeline for improved amyloid PET quantification of this atypical cohort. METHODS: The investigated data correction and amyloid quantification methods included motion correction, standardized uptake value ratio (SUVr) quantification using the parcellated MRI (standard method) and SUVr quantification without MRI. We introduced a novel amyloid analysis method yielding 2 biomarkers: AβL which quantifies the global Aβ burden and ns that characterizes the non-specific uptake. Cut-off points were first determined using visual assessment as ground truth and then using unsupervised classification techniques. RESULTS: Subject's motion impacts the accuracy of the measurement outcome but has however a limited effect on the visual rating and cut-off point determination. SUVr computation can be reliably performed for all the subjects without MRI parcellation while, when required, the parcellation failed or was of mediocre quality in 10% of the cases. The novel biomarker AβL showed an association increase of 29.5% with the cognitive tests and increased effect size between positive and negative scans compared with SUVr. ns was found sensitive to cerebral microbleeds, white matter hyperintensity, volume, and age. The cut-off points for SUVr using parcellated MRI, SUVr without parcellation, and AβL were 1.56, 1.39, and 25.5. Finally, k-means produced valid cut-off points without the requirement of visual assessment. CONCLUSION: The optimal processing for the amyloid quantification of this atypical cohort allows the quantification of all the subjects, producing SUVr values and two novel biomarkers: AβL, showing important increased in their association with various cognitive tests, and ns, a parameter sensitive to non-specific retention variations caused by age and cerebrovascular diseases.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Tanaka T, Stephenson MC, Nai YH, et al. Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease. Eur J Nucl Med Mol Imaging. 2019. PMID: 31863136. doi:10.1007/s00259-019-04642-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。